PortfoliosLab logoPortfoliosLab logo
ISRG vs. LLY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ISRG vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Intuitive Surgical, Inc. (ISRG) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ISRG achieves a -28.97% return, which is significantly lower than LLY's -0.64% return. Over the past 10 years, ISRG has underperformed LLY with an annualized return of 18.98%, while LLY has yielded a comparatively higher 32.48% annualized return.


ISRG

1D
-2.42%
1M
-12.12%
YTD
-28.97%
6M
-29.14%
1Y
-27.29%
3Y*
8.82%
5Y*
8.13%
10Y*
18.98%

LLY

1D
-1.67%
1M
10.66%
YTD
-0.64%
6M
2.07%
1Y
43.44%
3Y*
34.95%
5Y*
40.65%
10Y*
32.48%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ISRG vs. LLY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ISRG
Intuitive Surgical, Inc.
-28.97%8.51%54.72%27.14%-26.15%31.76%38.39%23.43%31.23%72.64%
LLY
Eli Lilly and Company
-0.64%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%

Correlation

The correlation between ISRG and LLY is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (3Y)
Calculated over the trailing 3-year period

0.30

Correlation (5Y)
Calculated over the trailing 5-year period

0.31

Correlation (10Y)
Calculated over the trailing 10-year period

0.31

Correlation (All Time)
Calculated using the full available price history since Jun 19, 2000

0.29

Fundamentals

Market Cap

ISRG:

$144.75B

LLY:

$953.37B

EPS

ISRG:

$8.24

LLY:

$28.14

PE Ratio

ISRG:

48.82

LLY:

37.81

PEG Ratio

ISRG:

2.99

LLY:

0.76

PS Ratio

ISRG:

13.74

LLY:

13.23

PB Ratio

ISRG:

8.23

LLY:

30.56

Total Revenue (TTM)

ISRG:

$10.58B

LLY:

$72.25B

Gross Profit (TTM)

ISRG:

$7.02B

LLY:

$59.75B

EBITDA (TTM)

ISRG:

$3.76B

LLY:

$32.97B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ISRG vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ISRG
ISRG Risk / Return Rank: 66
Overall Rank
ISRG Sharpe Ratio Rank: 66
Sharpe Ratio Rank
ISRG Sortino Ratio Rank: 77
Sortino Ratio Rank
ISRG Omega Ratio Rank: 99
Omega Ratio Rank
ISRG Calmar Ratio Rank: 88
Calmar Ratio Rank
ISRG Martin Ratio Rank: 22
Martin Ratio Rank

LLY
LLY Risk / Return Rank: 7272
Overall Rank
LLY Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 6969
Sortino Ratio Rank
LLY Omega Ratio Rank: 7070
Omega Ratio Rank
LLY Calmar Ratio Rank: 7373
Calmar Ratio Rank
LLY Martin Ratio Rank: 7474
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ISRG vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Intuitive Surgical, Inc. (ISRG) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ISRGLLYDifference

Sharpe ratio

Return per unit of total volatility

-0.89

1.15

-2.04

Sortino ratio

Return per unit of downside risk

-1.31

1.71

-3.02

Omega ratio

Gain probability vs. loss probability

0.85

1.23

-0.38

Calmar ratio

Return relative to maximum drawdown

-0.85

1.92

-2.76

Martin ratio

Return relative to average drawdown

-1.72

4.78

-6.50

ISRG vs. LLY - Sharpe Ratio Comparison

The current ISRG Sharpe Ratio is -0.89, which is lower than the LLY Sharpe Ratio of 1.15. The chart below compares the historical Sharpe Ratios of ISRG and LLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ISRGLLYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.89

1.15

-2.04

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.25

1.25

-1.00

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.59

1.08

-0.49

Sharpe Ratio (All Time)

Calculated using the full available price history

0.47

0.57

-0.10

Drawdowns

ISRG vs. LLY - Drawdown Comparison

The maximum ISRG drawdown since its inception was -82.26%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for ISRG and LLY.


Loading charts...

Drawdown Indicators


ISRGLLYDifference

Max Drawdown

Largest peak-to-trough decline

-82.26%

-68.24%

-14.02%

Max Drawdown (1Y)

Largest decline over 1 year

-32.14%

-23.64%

-8.50%

Max Drawdown (3Y)

Largest decline over 3 years

-34.10%

-34.48%

+0.38%

Max Drawdown (5Y)

Largest decline over 5 years

-49.90%

-34.48%

-15.42%

Max Drawdown (10Y)

Largest decline over 10 years

-49.90%

-34.48%

-15.42%

Current Drawdown

Current decline from peak

-34.10%

-5.56%

-28.54%

Average Drawdown

Average peak-to-trough decline

-21.27%

-19.22%

-2.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.79%

9.48%

+6.31%

Volatility

ISRG vs. LLY - Volatility Comparison

Intuitive Surgical, Inc. (ISRG) has a higher volatility of 10.94% compared to Eli Lilly and Company (LLY) at 9.11%. This indicates that ISRG's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ISRGLLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.94%

9.11%

+1.83%

Volatility (6M)

Calculated over the trailing 6-month period

20.19%

26.83%

-6.64%

Volatility (1Y)

Calculated over the trailing 1-year period

30.80%

37.88%

-7.08%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.15%

32.79%

+0.36%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.38%

30.15%

+2.23%

Dividends

ISRG vs. LLY - Dividend Comparison

ISRG has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.61%.


PositionTTM20252024202320222021202020192018201720162015
ISRG
Intuitive Surgical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.61%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%

Financials

ISRG vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Intuitive Surgical, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B20222023202420252026
2.77B
19.80B
(ISRG) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

ISRG vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Intuitive Surgical, Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

65.0%70.0%75.0%80.0%85.0%20222023202420252026
66.1%
79.0%
Portfolio components
ISRG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Intuitive Surgical, Inc. reported a gross profit of 1.83B and revenue of 2.77B. Therefore, the gross margin over that period was 66.1%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.

ISRG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Intuitive Surgical, Inc. reported an operating income of 855.30M and revenue of 2.77B, resulting in an operating margin of 30.9%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.

ISRG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Intuitive Surgical, Inc. reported a net income of 821.50M and revenue of 2.77B, resulting in a net margin of 29.7%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.


Frequently Asked Questions


ISRG and LLY have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ISRG has higher volatility (10.94%) compared to LLY (9.11%). In terms of maximum drawdown, ISRG dropped -82.26% vs LLY's -68.24%.

LLY currently has the higher Sharpe Ratio (1.15 vs -0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ISRG and LLY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer